To test the hypothesis that monoclonal antibody CAMPATH 1H currently being employed in the treatment of patients with active and refractory rheumatoid arthritis can be successfully used as retreatment of patients with this condition.
|Effective start/end date||10/1/92 → 9/30/93|
- National Center for Research Resources
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.